New ad urges Congress to take action on drug prices
The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, yesterday released a urging Congress to keep its commitment to lower drug prices. Seventeen organizations, including the AHA, this month urged Congress to resist any attempts from the pharmaceutical industry to undo during the lame duck session provisions included in the Bipartisan Budget Act to make prescription drugs more affordable for seniors. The legislation closes the Medicare Part D coverage gap or 鈥渄oughnut hole鈥 one year earlier and requires higher drug manufacturer discounts on brand name prescription drugs while enrollees are in the coverage gap.
Related News Articles
Headline
The Centers for Medicare and Medicaid Services May 30 released a notice requesting comments on a proposed Medicare Advantage service level data collection鈥
Headline
The AHA commented to the Centers for Medicare & Medicaid Services June 10 on the fiscal year 2026 inpatient prospective payment system proposed rule (https鈥
Headline
The AHA expressed concerns (LINK) to the Centers for Medicare & Medicaid Services today on payment updates for the fiscal year 2026 proposed rule for the鈥
Headline
The AHA commented on proposed changes to the Transforming Episode Accountability Model, a new, mandatory, episode-based payment model scheduled to begin Jan. 1鈥
Headline
The AHA June 10 commented on the fiscal year 2026 inpatient psychiatric facility proposed rule, expressing support for several provisions such as increases in鈥
Headline
The White House June 6 issued a memorandum directing the Secretary of the Department of Health and Human Services 鈥渢o take appropriate action to eliminate鈥